Founded in May 2012, the company is a wholly-owned subsidiary of Shandong Bainuo Pharmaceutical Co., LTD., located in Qihe, Shandong province, near the Yellow River known as the "Pearl of the Yellow River", covering an area of 200 mu, with a registered capital of 60 million yuan. The company has built API pilot trial, production base and preparation production base in accordance with international standards of Europe and the United States, and has 13 production lines for oral solid preparation, oral liquid preparation and API. Small volume injection, soft capsule, eye drops, external medicine and other preparation workshops, as well as innovative drug RESEARCH and development center are stepping up construction, and will eventually build into a comprehensive modern high-tech pharmaceutical enterprise integrating research and development, production and marketing of new pharmaceutical products.
Year Established: 2012
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 500-1000
Main Competitive Advantages: Experienced R&D Staff,Small Orders Accepted
Business Type: Manufacturer
R&D Capacity: OEM,ODM,Own Brand
Annual Turnover(USD) : 500,000 to 99,999,999
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect